Shares of Kanabo Group Plc (LON:KNB – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as GBX 0.92 ($0.01) and last traded at GBX 0.92 ($0.01), with a volume of 1250580 shares trading hands. The stock had previously closed at GBX 1.06 ($0.01).
Kanabo Group Stock Performance
The stock has a 50 day moving average price of GBX 1.16 and a two-hundred day moving average price of GBX 1.38. The company has a current ratio of 2.78, a quick ratio of 24.36 and a debt-to-equity ratio of 3.49. The company has a market cap of £5.94 million, a price-to-earnings ratio of -120.00 and a beta of 3.04.
Insider Activity
In other Kanabo Group news, insider Ian Mattioli bought 150,000 shares of Kanabo Group stock in a transaction on Tuesday, August 27th. The shares were purchased at an average cost of GBX 1 ($0.01) per share, for a total transaction of £1,500 ($1,945.27). 37.01% of the stock is currently owned by company insiders.
Kanabo Group Company Profile
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.
Featured Stories
- Five stocks we like better than Kanabo Group
- With Risk Tolerance, One Size Does Not Fit All
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- High Flyers: 3 Natural Gas Stocks for March 2022
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- What is a SEC Filing?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Kanabo Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kanabo Group and related companies with MarketBeat.com's FREE daily email newsletter.